Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1980-10-06
1982-03-23
Ford, John M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
546114, C07D49504, A61K 31395
Patent
active
043212662
ABSTRACT:
The free base, 5-o-cyanobenzyl-4,5,6,7-tetrahydrothieno [3,2-c] pyridine, a method for the preparation thereof, therapeutic compositions having blood-platelet aggregation inhibiting activity, therapeutic dosage units of the compositions, and a method for the treatment of warm-blooded animals to inhibit blood platelet aggregation, are described.
REFERENCES:
patent: 4051141 (1977-09-01), Castaigne
patent: 4075340 (1978-02-01), Maffrand
patent: 4076819 (1978-02-01), Maffrand
patent: 4097482 (1978-06-01), Amselem
patent: 4104390 (1978-08-01), Ferrand et al.
Maffrand et al., Eur. J. Med. Chem.--Chemica Therapeutica, Sep.-Oct. 1974, vol. 9, No. 5, pp. 483-486.
Podesta et al., Eur. J. Med. Chem.--Chemica Therapeutica, Sep.-Oct. 1974, vol. 9, No. 5, pp. 487-490.
Amselem Armand
Eloy Fernand
Maffrand Jean-Pierre
Ford John M.
Sanofi
LandOfFree
5-o-Cyanobenzyl-4,5,6,7-tetrahydrothieno [3,2-C] pyridine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-o-Cyanobenzyl-4,5,6,7-tetrahydrothieno [3,2-C] pyridine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-o-Cyanobenzyl-4,5,6,7-tetrahydrothieno [3,2-C] pyridine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1650792